Audience attending a Bio-PrecisionAI Health conference presentation

AI-Driven Biotech Innovation

Designing the next generation of small molecules, biologics, and oligonucleotide therapeutics.

Bio-PrecisionAI Health applies AI-guided discovery workflows to help research and biopharma teams move from biological insight to candidate design, biomarker discovery, and translational strategy.

Built for Translational Impact

We connect AI, molecular design, and scientific rigor so teams can prioritize the right targets, evaluate biomarker opportunities, and advance small molecule, biologic, and oligonucleotide programs with confidence.

AI-guided small molecule design

Focus discovery on higher-fidelity targets, chemotypes, and candidate refinement pathways.

Biologics and oligonucleotide discovery

Support modality selection and computational design strategies for next-generation therapeutic programs.

Biomarker and translational intelligence

Surface clinically relevant signals that support precision medicine and partner decision-making.

Joseph Tsenum representing Bio-PrecisionAI Health at an international biotech convention

About Us

Bio-PrecisionAI Health was founded on November 27, 2023 and incorporated in April 2024. We are building a sharper model for therapeutic discovery by integrating AI-guided design for small molecules, biologics, and oligonucleotides with biomarker discovery and scientific strategy.

  • Small molecule discovery with AI guidance

    We help teams rank targets, refine candidate hypotheses, and improve early-stage molecular design decisions.

  • Biologics and oligonucleotide innovation

    We support computational workflows that help evaluate biologic and oligonucleotide opportunities with stronger scientific direction.

  • Biomarker discovery and translational planning

    We analyze complex biological datasets to identify clinically meaningful signals that improve precision medicine strategy.

5

Leadership Team Members

3

Core Scientific Pillars

AI

Discovery-Native Workflows

End-to-End

Strategy to Execution

Services

We support biotech and research partners with focused services across discovery science, biomarker development, and AI strategy.

BioPharma Products

We support therapeutic strategy across small molecule, biologic, and oligonucleotide programs with a focus on scientific differentiation.

Platform Technology

Our platform approach combines data integration, predictive modeling, and workflow design to support better candidate design decisions.

Healthcare AI Consulting and Strategy Services

We work with organizations to define practical AI roadmaps that fit their scientific goals, teams, and operating realities.

Bioinformatics Consulting Services

We interpret genomic and multi-omics data to produce clearer biological signals, stronger hypotheses, and better research direction.

AI Drug Discovery Services

We apply AI-guided workflows to prioritize targets, rank candidate molecules, and support small molecule, biologic, and oligonucleotide discovery.

AI Biomarker Discovery Services

We identify biomarker opportunities that strengthen patient stratification, response prediction, and precision development planning.

Book a Discovery Call

Share your research goals, platform needs, or partnership interest and our team will follow up.

Loading
Your discovery call request has been sent successfully. Thank you!

Focus Areas

We work across the scientific and strategic areas required to turn AI insight into real therapeutic design decisions.

Small Molecules

We apply AI-guided workflows to improve target prioritization, molecular design, and early candidate selection.

Our team supports small molecule programs with computational insight that strengthens hit identification, optimization strategy, and scientific prioritization.

Biologics

Biologic programs demand careful integration of modality knowledge, target biology, and design strategy.

We support biologics-focused discovery planning with computational analysis that helps teams evaluate opportunities, refine direction, and reduce uncertainty early.

Oligonucleotides

Oligonucleotide discovery requires strong target logic, data interpretation, and modality-aware development planning.

We help teams evaluate oligonucleotide opportunities with AI-enabled analysis that supports program focus, biomarker alignment, and translational readiness.

Biomarker Discovery

Biomarkers sharpen precision medicine programs by connecting biological signals to patient relevance.

We interpret complex genomic and multi-omics datasets to identify biomarker opportunities that support patient stratification, response prediction, and translational planning.

Scientific Strategy

Strong discovery programs need more than models. They need clear scientific choices and executable direction.

We work with organizations to define practical discovery strategy across modality selection, computational workflows, biomarker use, and program execution priorities.

Leadership Team

The Bio-PrecisionAI Health team combines scientific leadership, computational depth, and company-building experience across drug discovery and AI.

Joseph Luper Tsenum
1

Joseph Luper Tsenum

Co-Founder, CEO, & R&D Director

Bio-PrecisionAI Health

josephtsenum@bioprecisionai.com

Victoria Harper-Alexander
2

Victoria Harper-Alexander

Co-Founder & Chief Scientific Officer

Bio-PrecisionAI Health

victoria.harperalexander@bioprecisionai.com

Dylan Tan
3

Dylan Tan

Chief Technology Officer

Bio-PrecisionAI Health

dylant@bioprecisionai.com

Laras Salsabila
4

Laras Salsabila

Chief Operating Officer

Bio-PrecisionAI Health

salsa@bioprecisionai.com

Ellie Okwei
5

Ellie Okwei

Head, Computational Drug Discovery

Bio-PrecisionAI Health

eokwei@bioprecisionai.com

Frequently Asked Questions

Common questions from organizations exploring partnerships with Bio-PrecisionAI Health.

What types of organizations do you work with?

We work with biotech, biopharma, research teams, and healthcare organizations that need support with discovery strategy, bioinformatics, biomarker identification, or AI planning.

Which services are best suited for early-stage discovery programs?

Our AI drug discovery, biomarker discovery, and bioinformatics services are especially useful when teams need help prioritizing targets, interpreting data, and shaping an evidence-based next step.

Do you offer strategic advisory services in addition to technical work?

Yes. We help teams assess AI opportunities, define realistic implementation roadmaps, and align scientific priorities with operational and commercial goals.

Can you support biomarker and precision medicine initiatives?

Yes. We work on biomarker discovery and translational analysis to help teams identify clinically relevant signals for patient stratification and program decision-making.

How do we start a conversation with your team?

You can use the contact form on this page or request a discovery call. Share a brief overview of your project and we will follow up with the right next step.

Do you tailor engagements to specific research needs?

Yes. We scope engagements around the scientific question, available data, program stage, and decision points that matter most to your team.

Testimonials

Client and partner testimonials will be shared here as they become available.

Contact

Reach Bio-PrecisionAI Health for discovery partnerships, scientific collaboration, and AI strategy inquiries.

Company

Bio-PrecisionAI Health

Loading
Your message has been sent. Thank you!